Thursday, Edwards Lifesciences Corp. (EW) reported fourth-quarter net income of $47.6 million or $0.80 per share, compared to net income of $38.1 million or $0.66 per share in the same quarter last year.
Excluding special items, net income was $49.8 million or $0.84 per share, compared to net income of $45.2 million or $0.78 per share in the year ago quarter.
On average, 25 analysts polled by Thomson Reuters expected the company to earn $0.85 per share for the quarter. Analysts' estimates typically exclude special items.
Net sales for the quarter increased 11.9% to $346.7 million from $309.7 million in the comparable quarter last year. Analysts expected the company to report revenue of $342.95 million for the quarter.
Looking ahead to the first quarter, the company expects earnings in the range of $0.77 - $0.81 per share. Analysts currently anticipate the company to earn $0.82 per share for the quarter.
For the full year 2010, the company reaffirmed its prior guidance and expects total sales, excluding special items, in the range of $1.43 billion - $1.50 billion with earnings in the range of $3.50 - $3.60 per share. Analysts currently anticipate the company to earn $3.56 per share on revenue of $1.47 billion for the year.
For comments and feedback contact: editorial@rttnews.com
June 12, 2026 17:14 ET Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.